GHP Q4 2022

NEWS Israeli startup Salignostics, which developed the SaliStick test kit, received the CE mark from the European authorities, has established a manufacturing facility in Israel, and is working to receive FDA approval in the US With SaliStick, a pregnancy test can be done anywhere and at any convenient time. The product is very simple, easy to use, and delivers accurate results in a few minutes Israeli startup Salignostics, the developer and provider of rapid saliva-based tests, is set to mass market SaliStick – the world’s first rapid saliva-based pregnancy test kit. Starting in the first quarter of 2023, SaliStick is expected to be available for purchase in several European countries, as well as South Africa, United Arab Emirates, and Israel. Salignostics is currently conducting discussions with various distributors in these territories. The kit has already been approved by the European CE certification and has received World’s first saliva-based pregnancy test set to arrive in stores in Europe, South Africa, and Israel in Q1-2023 Medical Devices and Accessories approval from Israel’s Ministry of Health. Salignostics has completed a 510(K) initial Q-submission of SaliStick to the FDA in the US. To support the commercialization of SaliStick, the company has established a new manufacturing facility in the Lavon Industrial Zone in Northern Israel with a monthly production capacity of 1 million units. SaliStick™ is the world’s only pregnancy home test that detects early pregnancy by saliva sampling instead of the known urine tests. With SaliStick, the test can be done anywhere and at any convenient time, with no need for a restroom. The test is very simple, easy to use, and delivers accurate results in no more than 10 minutes. According to the company’s Analysis, SaliStick is set to win significant market share due to its unique and innovative user experience. SaliStick will be presented at the Medica 2022 Trade Fair in Düsseldorf, Germany, which will take place between November 14th and November 17th. Salignostics’ booth will be located in Hall 1 / A18. Jerusalem-based Salignostics was founded in 2016 by a team of researchers at the Hebrew University of Jerusalem, who have many years of experience in cracking the secrets of saliva: Professor Aaron Palmon, Vice President for R&D at the Hebrew University; Dr. Omer Deutsch, who serves as CEO; Dr. Guy Krief, who serves as Deputy CEO and Director of Business Development; Dr. Raluca Cohen, who serves as Chief Scientific Officer; and Dr. Yoav Neumann, who serves as Senior Researcher. Salignostics’ Chief Commercialization Officer is Avraham Novogrocki (Novo), whose 35 years of executive experience includes management of large Israeli public companies. Following years of scientific research in saliva, the five founders began commercializing their intellectual property and developed user-friendly products to

RkJQdWJsaXNoZXIy MTQxNTg3MQ==